ATE79630T1 - Androstan-17-carbonsaeureester, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten. - Google Patents

Androstan-17-carbonsaeureester, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten.

Info

Publication number
ATE79630T1
ATE79630T1 AT88402476T AT88402476T ATE79630T1 AT E79630 T1 ATE79630 T1 AT E79630T1 AT 88402476 T AT88402476 T AT 88402476T AT 88402476 T AT88402476 T AT 88402476T AT E79630 T1 ATE79630 T1 AT E79630T1
Authority
AT
Austria
Prior art keywords
group
image
carbon atoms
hydroxy
lower alkyl
Prior art date
Application number
AT88402476T
Other languages
English (en)
Inventor
Francois-Xavier Jarreau
Jean-Jacques Koenig
Original Assignee
Nativelle Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nativelle Lab filed Critical Nativelle Lab
Application granted granted Critical
Publication of ATE79630T1 publication Critical patent/ATE79630T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Cephalosporin Compounds (AREA)
AT88402476T 1987-10-02 1988-09-30 Androstan-17-carbonsaeureester, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten. ATE79630T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8713658A FR2621316B1 (fr) 1987-10-02 1987-10-02 Nouveaux esters d'acide androstane 17-carboxylique, procede pour leur preparation, et medicament les contenant
EP88402476A EP0310519B1 (de) 1987-10-02 1988-09-30 Androstan-17-carbonsäureester, Verfahren zu ihrer Herstellung und Arzneimittel, die sie enthalten

Publications (1)

Publication Number Publication Date
ATE79630T1 true ATE79630T1 (de) 1992-09-15

Family

ID=9355472

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88402476T ATE79630T1 (de) 1987-10-02 1988-09-30 Androstan-17-carbonsaeureester, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten.

Country Status (22)

Country Link
US (1) US4885280A (de)
EP (1) EP0310519B1 (de)
JP (1) JP2783560B2 (de)
KR (1) KR970002642B1 (de)
AT (1) ATE79630T1 (de)
AU (1) AU607100B2 (de)
CA (1) CA1306248C (de)
DE (1) DE3873870T2 (de)
DK (1) DK165595C (de)
EG (1) EG19114A (de)
ES (1) ES2052761T3 (de)
FI (1) FI89055C (de)
FR (1) FR2621316B1 (de)
GR (1) GR3005968T3 (de)
HK (1) HK60297A (de)
IE (1) IE61941B1 (de)
IL (1) IL87894A (de)
MY (1) MY103635A (de)
NO (1) NO173011C (de)
NZ (1) NZ226433A (de)
PT (1) PT88648B (de)
ZA (1) ZA887396B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5209926A (en) * 1990-06-12 1993-05-11 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5256408A (en) * 1990-06-12 1993-10-26 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5252319A (en) * 1990-06-12 1993-10-12 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
WO1993005790A1 (en) * 1991-09-27 1993-04-01 Procter & Gamble Pharmaceuticals, Inc. Use of 14-aminosteroids for the manufacture of a medicament to slow the rate of progression of myocardial structural damages characteristic of congestive heart failure
US5629295A (en) * 1992-06-26 1997-05-13 Pfizer Inc. Steroidal glycosides for treating hypercholesterolemia
CZ86796A3 (en) * 1993-09-24 1996-10-16 Procter & Gamble Novel deoxy and on oxygen substituted sugar derivatives of aminosteroidal compounds
WO1995008557A1 (en) * 1993-09-24 1995-03-30 The Procter & Gamble Company Novel oligosaccharide-containing 14-aminosteroid compounds and novel diastereoselective aminosteroid process chemistry
US5922703A (en) * 1993-09-24 1999-07-13 The Procter & Gamble Company Urethane-containing aminosteroid compounds
AU700131B2 (en) * 1993-09-24 1998-12-24 Procter & Gamble Company, The Novel deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds
CA2258202A1 (en) * 1996-06-17 1997-12-24 The Procter & Gamble Company Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds for use as an antiarrhythmic
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
EP1945240B1 (de) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Zusammensetzungen mit rezeptor-assoziierten protein (rap) varianten, die für cr-haltige proteine spezifisch sind und ihre verwendungen
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
GB201112402D0 (en) 2011-07-19 2011-08-31 British American Tobacco Co Cellulose acetate compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449381A (en) * 1962-06-12 1969-06-10 Syntex Corp 19-oxo- and 19-lower alkyl-19-oxoandrostane derivatives
US3634409A (en) * 1966-04-26 1972-01-11 Syntex Corp 3beta-tetrahydrofuran-2'-yloxy-delta**4-steroids of the androstane and estrane series
FR2464270A1 (fr) * 1979-08-31 1981-03-06 Nativelle Sa Ets Nouveaux derives d'amino-14 steroides, et procede pour leur preparation
NZ205293A (en) * 1982-08-20 1986-12-05 Nativelle Sa Ets 14-aminosteroids and pharmaceutical compositions
ES8404694A1 (es) * 1982-08-20 1984-05-01 Nativelle Sa Ets Procedimiento de preparacion de nuevos derivos de amino-14 esteroides

Also Published As

Publication number Publication date
MY103635A (en) 1993-08-28
PT88648A (pt) 1988-10-01
ZA887396B (en) 1991-11-27
FR2621316B1 (fr) 1991-06-21
CA1306248C (en) 1992-08-11
EP0310519B1 (de) 1992-08-19
GR3005968T3 (de) 1993-06-07
AU607100B2 (en) 1991-02-21
JPH01156995A (ja) 1989-06-20
FI89055B (fi) 1993-04-30
DK165595C (da) 1993-05-03
FI89055C (fi) 1993-08-10
KR970002642B1 (ko) 1997-03-07
NO173011C (no) 1993-10-13
DE3873870T2 (de) 1993-02-18
DE3873870D1 (de) 1992-09-24
NO884344L (no) 1989-04-03
ES2052761T3 (es) 1994-07-16
FI884511A7 (fi) 1989-04-03
IL87894A (en) 1994-02-27
PT88648B (pt) 1992-12-31
IE61941B1 (en) 1994-11-30
EG19114A (fr) 1994-07-30
DK165595B (da) 1992-12-21
JP2783560B2 (ja) 1998-08-06
DK549388D0 (da) 1988-09-30
HK60297A (en) 1997-05-16
IL87894A0 (en) 1989-03-31
EP0310519A1 (de) 1989-04-05
NO884344D0 (no) 1988-09-30
DK549388A (da) 1989-04-03
KR890006667A (ko) 1989-06-15
NO173011B (no) 1993-07-05
NZ226433A (en) 1991-06-25
FR2621316A1 (fr) 1989-04-07
AU2293588A (en) 1989-04-06
US4885280A (en) 1989-12-05
IE882991L (en) 1989-04-02
FI884511A0 (fi) 1988-09-30

Similar Documents

Publication Publication Date Title
ATE79630T1 (de) Androstan-17-carbonsaeureester, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten.
CA2056596A1 (en) 2-substituted adenosine derivatives and pharmaceutical compositions for circulatory diseases
RU97101087A (ru) Применение соединений стерина для получения лекарственного средства, регулирующего мейоз и способ регулирования мейоза
DE69023947D1 (de) Fluorierte Gallensäure-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen daraus.
ATE43840T1 (de) Heterocyclische stickstoffverbindungen, ihre herstellung und heilmittel die sie enthalten.
NO964667L (no) Purin-6-on-derivater
ATE48602T1 (de) Beta-carboline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DE69020781D1 (de) Gallensäure-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen daraus.
PT86735A (pt) Pyridin-2,4- und 2,5-dicarbonsaeure-derivate verfahren zu ihrer herstellung verwendung derselben sowie arzneimittel auf basis dieser verbindungen
DK163055C (da) Analogifremgangsmaade til fremstilling af 2-dipropylamino-(5 eller 7)-formylamino-6-hydroxy-1,2,3,4-tetrahydronaphthalen og farmakologisk acceptable syreadditionssalte deraf
ATE5961T1 (de) N-acylpeptid-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE28077T1 (de) Aminoderivate von in stellung 6 durch ein heterocyclisch oder ein alicyclisch substituiertes pyridazin, verfahren zu deren herstellung und heilmittel die sie enthalten.
ATE11912T1 (de) ((indol-3-yl)-3-amino-2-propionyloxy)-2essigs|urederivate, verfahren zu ihrer herstellung und heilmittel, die sie enthalten.
ATE70838T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
ATE13676T1 (de) Delta-1,3,5-3-chlor-11-beta,16-alpha,17-alpha,2 - tetra-(hydroxy)-pregnan-20-on-16,17acetonidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE77379T1 (de) Neue imidazo- und triazolothiadiazine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung, sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte.
ATE81126T1 (de) Benzopyrrolidinon-derivate, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten.
PT75900A (de) Neue oxyme von 3'''-dehydro-cardenolid-trididitoxosiden verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69306513D1 (de) Neue kardioaktive Zyklopentaperhydrophenanthrene-17-beta-(hydroxy oder alkoxy)-17-alpha-(aryl oder heterozyklyl)-3-beta Derivate, ein Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon
ES8303405A1 (es) Procedimiento de preparacion de derivados de quinidina.
ATE11530T1 (de) P-chlorophenoxyessigsaeure-derivat, verfahren zu dessen herstellung und pharmazeutische zusammenstellung.
DE3415100A1 (de) Neue 2,3-diamino-2,3-didesoxyhexosederivate, verfahren zu ihrer herstellung und ihre verwendung
DE3766914D1 (de) Tricyclische benzotriazole, verfahren zu ihrer herstellung sowie arzneimittel.
SE7806445L (sv) Alkanolaminderivat och sett for deras framstellning
DE3482857D1 (de) 3-aryl-3-pyrrolin-derivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel fuer die bekaempfung von herz- und gefaesskrankheiten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee